CTX-009
202602098
Phase 2 small_molecule active
Quick answer
CTX-009 for Glioblastoma is a Phase 2 program (small_molecule) at Compass Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Compass Therapeutics
- Indication
- Glioblastoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active